Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061464
Status:
COMPLETED
Last Update Posted:
2007-01-26
First Post:
2003-05-28
Brief Title:
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy
Sponsor:
Organization:
Eli Lilly and Company